Information  X 
Enter a valid email address

Westpac Banking. (60IP)

  Print      Mail a friend

Tuesday 19 June, 2012

Westpac Banking.

Publication of Supplementary Prospectus

RNS Number : 7133F
Westpac Banking Corporation
19 June 2012
 



Westpac Banking Corporation

 

Publication of Supplementary Prospectus

 

The following Supplementary Prospectus has been approved by the United Kingdom Listing Authority (the "UKLA") and is available for viewing:

 

Supplementary Prospectus dated 19 June 2012 (the "Supplementary Prospectus") to the Base Prospectus dated 16 November 2011 as amended by the supplementary prospectuses dated 8 December 2011, 30 December 2011 and 14 May 2012 (together, the "Base Prospectus"), relating to the Programme for the Issuance of Debt Instruments established by Westpac Banking Corporation. 

 

To view the Supplementary Prospectus in full, please paste the following URL into the address bar of your browser:

 

http://www.rns-pdf.londonstockexchange.com/rns/7133F_-2012-6-19.pdf 

 

A copy of the Supplementary Prospectus has been submitted to the National Storage Mechanism and will shortly be available for inspection at www.Hemscott.com/nsm.do

 

For further information, please contact:

 

Susan Ehr
Westpac Banking Corporation
Camomile Court
23 Camomile Street

London  EC3A 7LL

 

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Base Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Base Prospectus is not addressed.  Prior to relying on the information contained in the Base Prospectus you must ascertain from the Base Prospectus whether or not you are part of the intended addressees of the information contained therein.

 

This publication does not constitute an offering of debt instruments (the "Instruments"), and is not for distribution in or into the United States. The Instruments have not been and will not be registered under the United States Securities Act of 1933 as amended (the "Securities Act"), or any relevant securities laws of any state of the United States and, subject to certain exceptions, the Instruments may not be offered, sold or delivered in the United States or to, or for the account or benefit of, U.S. persons, as such terms are defined in Regulation S under the Securities Act.  Instruments in bearer form are subject to U.S. tax law requirements and may not be offered, sold or delivered within the United States or its possessions or to a U.S. person, except in certain transactions permitted by U.S. tax regulations.  Terms used in the preceding sentence have the meanings given to them by the U.S. Internal Revenue Code and regulations thereunder. There will be no public offering of the Instruments in the United States.

 

Your right to access this service is conditional upon complying with the above requirement.  In particular, your accessing this service will constitute your representation that you are not in the United States and you are not a U.S. person within the meaning of Regulation S under the Securities Act and the U.S. Internal Revenue Code and regulations thereunder.

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PDIZKLFFLQFXBBD